Lead Optimization and Preclinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R43/R44)

Funding Opportunity ID: 291407 Opportunity Number: PA-17-130 Opportunity Title: Lead Optimization and Preclinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R43/R44)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCategory Explanation: CFDA Number(s): 93.847Eligible Applicants: Small businessesAdditional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.Agency Code: HHS-NIH11Agency Name: Department of Health and Human ServicesNational Institutes of HealthPosted Date: Jan 24, 2017Close Date: Jan 05, 2020 Last Updated Date: Jan 24, 2017Award Ceiling: Award Floor: Estimated Total Program Funding: Expected Number of Awards: Description: The goal of this Funding Opportunity Announcement (FOA) is to support lead optimization and preclinical development of new therapies for diseases within the mission of the NIDDK with the SBIR program. SBIR Phase I projects under this FOA supportpreliminary steps in the process for lead optimization or preclinical development of therapeutics. SBIR Phase II supports lead optimization and preclinical development of...
Source: Grants.gov - Category: Research Tags: Food and Nutrition Health Source Type: funding